share_log

ETRACS 2x Leveraged US Size Factor TR ETN (NYSEARCA:IWML) Trading Down 1.2%

ETRACS 2x Leveraged US Size Factor TR ETN (NYSEARCA:IWML) Trading Down 1.2%

ETRAS 2 倍槓桿式美國規模因數 TR ETN (紐約證券代碼:IWML) 交易指數下跌 1.2%
Defense World ·  2022/12/28 01:11

ETRACS 2x Leveraged US Size Factor TR ETN (NYSEARCA:IWML – Get Rating)'s share price fell 1.2% on Tuesday . The stock traded as low as $14.91 and last traded at $14.91. 30 shares changed hands during trading, a decline of 97% from the average session volume of 1,019 shares. The stock had previously closed at $15.09.

ETRACS2X槓桿式美國規模因數TRETN(NYSEARCA:IWML-GET Rating)的股價週二下跌1.2%。該股最低交易價格為14.91美元,最新報14.91美元。30股股票在交易中易手,較1,019股的平均交易量下降了97%。該股此前收盤時為15.09美元。

ETRACS 2x Leveraged US Size Factor TR ETN Trading Down 1.2 %

ETRACS 2x槓桿式美國規模因素TRETN交易下跌1.2%

The firm has a 50-day simple moving average of $16.00 and a two-hundred day simple moving average of $15.95.

該公司的50日簡單移動均線切入位在16.00美元,200日簡單移動均線切入位在15.95美元。

Further Reading

進一步閱讀

  • Get a free copy of the StockNews.com research report on ETRACS 2x Leveraged US Size Factor TR ETN (IWML)
  • 3 Industrial Stocks to Help Build Your 2023 Watchlist
  • The Institutions Choose CarMax Over Carvana, Should You?
  • Heatmap in Trading: How to Learn What Market Depth Hides
  • Micron Technology Sees Chip Recovery by the End of 2023
  • Three Healthcare Penny Stocks to Watch In The New Year
  • 免費獲取StockNews.com關於ETRACS 2x槓桿式美國規模係數TRETN(IWML)的研究報告
  • 幫助你建立2023年觀察名單的3只工業股票
  • 這些機構選擇CarMax而不是Carvana,你應該這樣做嗎?
  • 交易熱圖:如何瞭解隱藏的市場深度
  • 美光科技預計2023年底晶片回收
  • 新年值得關注的三隻醫療保健便士股

Receive News & Ratings for ETRACS 2x Leveraged US Size Factor TR ETN Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ETRACS 2x Leveraged US Size Factor TR ETN and related companies with MarketBeat.com's FREE daily email newsletter.

獲得ETRACS 2x槓桿式美國規模因數TRETN Daily的新聞和評級-在下面輸入您的電子郵件地址,以通過MarketBeat.com的免費每日電子郵件時事通訊接收最新新聞和分析師對ETRACS 2x槓桿式美國規模因數TRETN和相關公司評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論